Brii Biosciences Limited (HKG:2137)
Hong Kong
· Delayed Price · Currency is HKD 2.090
+0.140 (7.18%)
May 2, 2025, 4:08 PM HKT
Brii Biosciences Market Cap
Brii Biosciences has a market cap or net worth of 1.50 billion as of May 2, 2025. Its market cap has increased by 119.15% in one year.
Market Cap
1.50B
Enterprise Value
-990.46M
Revenue
58.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.09
Market Cap Chart
Since July 13, 2021, Brii Biosciences's market cap has decreased from 16.21B to 1.50B, a decrease of -90.73%. That is a compound annual growth rate of -46.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2025 | 1.40B | 95.68% |
| Dec 31, 2024 | 716.67M | -56.90% |
| Dec 29, 2023 | 1.66B | -68.96% |
| Dec 30, 2022 | 5.36B | -77.39% |
| Dec 31, 2021 | 23.70B | 46.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 213.68B |
| Hansoh Pharmaceutical Group Company | 145.08B |
| JD Health International | 122.47B |
| WuXi Biologics | 97.65B |
| Innovent Biologics | 90.48B |
| Alibaba Health Information Technology | 82.83B |
| Akeso | 78.81B |
| Sichuan Kelun-Biotech Biopharmaceutical | 78.13B |